Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon SL for Acute Depressive Episodes in Bipolar I Disorder
NCT01467700Phase 3Terminated
- Sponsor
- Takeda
- Start
- Dec 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of ramelteon in bipolar I disorder, sponsored by Takeda. Started Dec 2011; status: terminated.
02
Drugs
ramelteon
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01467700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01467700.